The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome.
Cesar SierraMiguel Sabariego-NavarroÁlvaro Fernández-BlancoSonia CrucianiAlfonsa Zamora-MoratallaEva Maria NovoaMara DierssenPublished in: Molecular psychiatry (2024)
Down syndrome (DS) stands as the prevalent genetic cause of intellectual disability, yet comprehensive understanding of its cellular and molecular underpinnings remains limited. In this study, we explore the cellular landscape of the hippocampus in a DS mouse model, the Ts65Dn, through single-nuclei transcriptional profiling. Our findings demonstrate that trisomy manifests as a highly specific modification of the transcriptome within distinct cell types. Remarkably, we observed a significant shift in the transcriptomic profile of granule cells in the dentate gyrus (DG) associated with trisomy. We identified the downregulation of a specific small nucleolar RNA host gene, Snhg11, as the primary driver behind this observed shift in the trisomic DG. Notably, reduced levels of Snhg11 in this region were also observed in a distinct DS mouse model, the Dp(16)1Yey, as well as in human postmortem brain tissue, indicating its relevance in Down syndrome. To elucidate the function of this long non-coding RNA (lncRNA), we knocked down Snhg11 in the DG of wild-type mice. Intriguingly, this intervention alone was sufficient to impair synaptic plasticity and adult neurogenesis, resembling the cognitive phenotypes associated with trisomy in the hippocampus. Our study uncovers the functional role of Snhg11 in the DG and underscores the significance of this lncRNA in intellectual disability. Furthermore, our findings highlight the importance of DG in the memory deficits observed in Down syndrome.
Keyphrases
- long non coding rna
- poor prognosis
- intellectual disability
- single cell
- mouse model
- autism spectrum disorder
- wild type
- genome wide
- cerebral ischemia
- traumatic brain injury
- gene expression
- working memory
- endothelial cells
- randomized controlled trial
- rna seq
- cell proliferation
- metabolic syndrome
- copy number
- multiple sclerosis
- adipose tissue
- cell therapy
- insulin resistance
- stem cells
- dna methylation
- transcription factor
- signaling pathway
- cognitive impairment
- single molecule
- type diabetes
- induced pluripotent stem cells
- skeletal muscle
- resting state
- prefrontal cortex